KYLIE JIMENEZ: Open Payments
NPI 1720724701 · ROCKAWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 42 payments from 10 companies in 2025. Trend: 2023 $771 · 2024 $546 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $181 |
| ABBVIE INC. | 10 | $166 |
| Ardelyx, Inc. | 5 | $86 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $47 |
| PFIZER INC. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REZDIFFRA, IBSRELA, ZENPEP, LINZESS, ENTYVIO, RINVOQ, INJECTAFER, VELSIPITY.
Industry payments across NJ — which companies pay providers there.
